BioNTech SE - American Depositary Shares
(BNTX)

BioNTech SE - American Depositary Shares

22:59:14 · Nasdaq

22:59:14 · Valuta i USD

Nasdaq

Senast

105,97

Idag %

−0,30%

Idag +/-

−0,32

Köp

105,29

Sälj

106,00

Högst

110,86

Lägst

103,02

Omsatt (Antal)

0,00

22:59:14 · Nasdaq

22:59:14 · Valuta i USD

Nasdaq

BioNTech SE - American Depositary Shares

22:59:14 · Nasdaq · Valuta i USD

22:59:14 · Valuta i USD

Nasdaq

Senast

105,97

Utveckling idag

−0,30%

−0,32

Köp

105,29

Sälj

106,00

Högst

110,86

Lägst

103,02

Omsatt (Antal)

0,00

Utveckling

Visa volym

Orderdjup

Ingen data hittades

Senaste avslut

Tid	Pris	Antal	Köpare	Säljare
-		-	-	-

Volymvägt snittpris (VWAP)

VWAP

Omsättning (USD)

126 760 239

Mäklarstatistik

Ingen data hittades

Företagshändelser

Det finns inga angivna utdelningar

Nyheter & Analyser

Utveckling

Visa volym

Inga Nordnet Markets Certifikat finns med underliggande värdepapper.

Nyheter & Analyser

Företagshändelser

Det finns inga angivna utdelningar

Orderdjup

Ingen data hittades

Senaste avslut

Tid	Pris	Antal	Köpare	Säljare
-		-	-	-

Volymvägt snittpris (VWAP)

VWAP

Omsättning (USD)

126 760 239

Mäklarstatistik

Ingen data hittades

Företagshändelser

Det finns inga angivna utdelningar

*Kommentarerna ovan kommer från shareville.se och har varken redigerats eller granskats av Nordnet. De innebär inte att Nordnet tillhandahåller investeringsrådgivning eller investeringsrekommendationer. Nordnet påtar sig inget ansvar för kommentarerna.

Nyckeldata

P/E
-
P/E*
-
P/B
-
P/S
-
Utdelning/aktie
-
EPS
-
Direktavkastning
-
EPS tillväxt*
-
PEG
-

*Baserat på estimat

Finansiell översikt

Resultaträkning ()

category_local

Balansräkning ()

category_local

Kassaflöde ()

category_local

Bolagsöversikt

Företagsnamn	-
VD	-
E-post	-
Hemsida	-
Säte	-
Antal anställda	-
Antal aktier	-
Börsvärde	-

Om värdepapperet

Namn	BioNTech SE - American Depositary Shares
ISIN	-
Sektor	-
Bransch	-
Kortnamn	BNTX
Introduktionsdatum	-
Belåningsgrad	-
Säkerhetskrav	200%

United States of AmericaBioNTech SE - American Depositary Shares(BNTX)

United States of AmericaBioNTech SE - American Depositary Shares(BNTX)

United States of AmericaBioNTech SE - American Depositary Shares

United States of AmericaBioNTech SE - American Depositary Shares

United States of AmericaBioNTech SE - American Depositary Shares

United States of AmericaBioNTech SE - American Depositary Shares

Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19

Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture

An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission

BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science

BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

Correction: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program

Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine

Mest handlade

Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19

Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture

An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission

BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science

BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

Correction: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program

Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine

Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19

Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture

An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission

BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science

BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

Correction: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program

Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine

Resultaträkning ()

Balansräkning ()

Kassaflöde ()

Om värdepapperet

BioNTech SE - American Depositary Shares
(BNTX)